CytoMed Therapeutics Insider Trades
NASDAQ: GDTCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 5 · $728.78K
- Sales
- 0 · $0
- Shares bought / sold
- 512.00K / 0
- Net activity
- Net buying $728,778
CytoMed Therapeutics insider activity
Over the last 12 months, CytoMed Therapeutics insiders reported 5 transactions on SEC Form 4: 5 open-market purchases and 0 sales. Insiders bought $728,778 and sold $0 worth of stock, for net insider buying of $728,778. The most recent filing shows Choo Chee Kong (Director) buying 100,000 shares at $1.50 on Jul 20, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put GDTC's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
GDTC insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jul 20, 2026 | Choo Chee KongDirector | Buy | 100,000 | $150.00K | Form 4 |
| Jul 20, 2026 | Choo Chee KongDirector | Buy | 100,000 | $150.00K | Form 4 |
| Jul 14, 2026 | Choo Chee KongDirector | Buy | 100,000 | $150.00K | Form 4 |
| Jul 14, 2026 | Choo Chee KongDirector | Buy | 100,000 | $150.00K | Form 4 |
| May 13, 2026 | Choo Chee KongDirector | Buy | 112,000 | $128.78K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4